London: The Oxford-AstraZeneca vaccine, whose Indian version is Covishield, is going through a rough phase. After 8 European nations temporarily suspended the vaccine due to possible blood clots, countries like Thailand are delaying its rollout.
The European Union’s drug regulator has now recommended adding severe allergy (anaphylaxis and hypersensitivity) as possible side effects.
This is based on 41 reports of possible anaphylaxis from around 5 million vaccinations in the UK.
It is important to note that the European Medicines Agency (EMA) is investigating the development of blood clots post vaccination, that prompted Italy, Norway and Denmark to suspend the jab. EMA, however, added that the vaccine is safe for use.
Anaphylaxis is known to be a common reaction to vaccines. The AstraZeneca shot carries a label that advises patients be kept under close observation for 15 minutes.
Also Read: Eight EU Nations Stop Using AstraZeneca Vaccine
Mumbai: Ananya Panday and Aditya Roy Kapur were one of the most talked-about couples of…
Balangir: Former MLA Jagneswar Babu, who left Congress recently, joined Bharatiya Janata Party in Odisha's…
Ayodhya: Prime Minister Narendra Modi held a grand roadshow here on Sunday evening after offering…
Puri: Congress' candidate for Puri Sadar Assembly constituency in Odisha Uma Ballav Rath was allegedly…
Bhubaneswar: A total of 115 boys and girls from Nepal, Canada, USA and host country…
New Delhi: Kishori Lal Sharma, Congress’ surprise choice for Amethi Lok Sabha constituency, said on…
Puri: The under-production Odia film 'Ashram' will be released in cinema theatres across Odisha in…
New Delhi: The Council for the Indian School Certificate Examinations (CISCE) will announce results for…